Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Autologous Human Umbilical Cord Blood for Pediatric TBI
NCT01251003Phase 2Withdrawn
- Start
- Jan 2011
- Primary completion
- Dec 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous umbilical cord blood in traumatic brain injury (TBI). Planned start Jan 2011; status: withdrawn.
02
Drugs
autologous umbilical cord blood
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01251003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251003.